A few cases of Takotsubo cardiomyopathy with apical hypertrophic cardiomyopathy (APH)-like
morphological changes during the recovery process have been reported[1],[2],[3]). Furthermore, a single-center prospective study that included
patients with Takotsubo cardiomyopathy who showed APH-like morphological changes during the
recovery process reported the incidence, characteristics, and clinical outcomes[4]).We report a case in which the apical left ventricular thrombus was complicated in the acute
phase of Takotsubo cardiomyopathy and showed an APH-like morphology during recovery. We
examined this patient using 2D speckle-tracking echocardiography, based on the method used
for hypertrophic cardiomyopathy[5],
[6]). We have obtained
informed consent for this manuscript.
Case report
A 56-year-old woman, admitted to the psychiatric department for treatment of schizophrenia,
had unstable dietary intake, received an intravenous drip from the peripheral vein, and was
monitored via electrocardiography. On the 24th day after admission, despite the absence of
any subjective symptoms, the nurse noticed an abnormal electrocardiogram and consulted with
our cardiology department. The patient’s vital signs were as follows: body temperature,
37.4°C; blood pressure, 98/70 mmHg; heart rate 69/min, and SPO2, 95% in room air.
The electrocardiogram showed giant negative T waves in the I, II, III, aVF, and V2-6 leads
(Figure 1A), and the QT interval was extended to 490 ms. Furthermore, a positive T wave was seen
in the aVR and V1 leads, which has been previously reported to strongly suggest Takotsubo
cardiomyopathy rather than myocardial infarction[7]). Echocardiography showed extensive left ventricular asynergy,
except in the basal part of the heart. The apex of the heart presented with ballooning,
which showed a morphology consistent with that of Takotsubo cardiomyopathy (Figure 1A). The left ventricular ejection fraction
(LVEF) was 48.9%, left ventricular end-diastolic diameter (LVDd) was 45 mm, left ventricular
end-diastolic volume (LVEDV) was 78 mL, left ventricular end-systolic diameter (LVDs) was 27
mm, and left ventricular end-systolic volume (LVESV) was 37 mL. There was no congestion on a
chest radiograph, with a cardiothoracic ratio of 46%. Blood test results showed a slight
increase in creatine phosphokinase (585 U/L), creatine phosphokinase-MB (10 U/L), and
troponin I (312 ng/mL). However, because the degree of elevation of these myocardial
deviation enzymes and that of myocardial damage was inconsistent, Takotsubo cardiomyopathy
was strongly suspected rather than myocardial infarction. No electrolyte abnormalities or
antipsychotics causing myocardial damage were observed. Coronary computed tomography
angiography revealed no significant stenosis in the coronary arteries. Unfortunately,
because coronary angiography was infeasible in our case owing to the patient’s psychiatric
condition, it was difficult to determine if vasospastic angina was present. By
comprehensively evaluating these test results, we diagnosed the patient with takotsubo
cardiomyopathy. Apical thrombosis was documented, and anticoagulant therapy with heparin and
warfarin was initiated. We did not administer any other drugs, and only followed the patient
at rest. Echocardiography on the 18th day of hospitalization showed a morphology similar to
that of APH (Figure 1B; LVEF, 73%; LVDd, 50 mm;
LVDs, 26 mm; LVEDV, 60 mm; LVESV, 16 mm), and a giant negative T wave in the V3-4 lead was
found on electrocardiogram, showing changes characteristic of APH (Figure 1B). A pressure gradient was not observed in the left
ventricle. The patient had no subjective symptoms, vital signs were stable, and there were
no signs of heart failure. Despite similar case reports in the literature[1],[2],[3]) no specific treatment has been reported; thus, we continued
with the follow-up. The APH-like findings disappeared after approximately 5 months (Figure 1C; LVEF: 74%; LVDd: 47 mm; LVDs: 27 mm; LVEDV,
63.2 mL; LVESV: 20.1 mL). We examined the patient using 2D speckle-tracking
echocardiography, based on the method used for hypertrophic cardiomyopathy[6]). We measured the circumferential
strain (CS) and longitudinal strain (LS) of endocardial, middle, and epicardial layers. The
images of the CS in each layer at the apex are shown in Figure 2, and the CS and LS values in each layer are shown in Figure 3. Previously reported normal values for each layer of the CS and LS were used as a
reference[8]). At the early
stage of onset, the inner layer CS (CSinner), middle layer CS (CSmid), and outer layer CS
(CSouter) at the apex showed a marked decrease. Echocardiography performed when an APH-like
morphology was observed during the recovery process of Takotsubo cardiomyopathy showed a
sharp improvement in the CSinner. Echocardiography performed at the time of normalization of
myocardial morphology and wall motion showed a normalized CSinner. LSinner, LSmid, and
LSouter at the apex were not normalized despite the disappearance of the APH-like morphology
and normalization of wall motion.
Figure 1
Electrocardiogram and echocardiographic images.
The electrocardiogram and echocardiographic images at the time of onset (A), at the
time of APH-like morphological changes (B), and at the time when the morphology and
wall motion were normalized (C) are shown.
Figure 2
Representative images of the circumferential strain.
Representative images of the circumferential strain for each layer in the apex at the
time of onset (A), APH-like morphological changes (B), and when the morphology and
wall motion were normalized (C) are shown. GS stands for global circumferential
strain.
Figure 3
The values of the circumferential strain and the longitudinal strain.
The values of the circumferential strain (CS) and longitudinal strain (LS) for the
endocardial, middle, and epicardial layers at the time of onset (A), at the time of
APH-like morphological changes (B), and at the time when the morphology and wall
motion were normalized (C) are shown. The colored bars in the graph show the normal
values of CS in each region. The normal values of LS in each region are shown in
parentheses. In the apex, CS at the onset was severely reduced in all layers, but
CSinner showed rapid improvement thereafter. CSouter: outer layer CS; CSmid: middle
layer CS; CSinner: inner layer CS; LSouter: outer layer LS; LSmid: middle layer LS;
LSinner: inner layer LS.
Electrocardiogram and echocardiographic images.The electrocardiogram and echocardiographic images at the time of onset (A), at the
time of APH-like morphological changes (B), and at the time when the morphology and
wall motion were normalized (C) are shown.Representative images of the circumferential strain.Representative images of the circumferential strain for each layer in the apex at the
time of onset (A), APH-like morphological changes (B), and when the morphology and
wall motion were normalized (C) are shown. GS stands for global circumferential
strain.The values of the circumferential strain and the longitudinal strain.The values of the circumferential strain (CS) and longitudinal strain (LS) for the
endocardial, middle, and epicardial layers at the time of onset (A), at the time of
APH-like morphological changes (B), and at the time when the morphology and wall
motion were normalized (C) are shown. The colored bars in the graph show the normal
values of CS in each region. The normal values of LS in each region are shown in
parentheses. In the apex, CS at the onset was severely reduced in all layers, but
CSinner showed rapid improvement thereafter. CSouter: outer layer CS; CSmid: middle
layer CS; CSinner: inner layer CS; LSouter: outer layer LS; LSmid: middle layer LS;
LSinner: inner layer LS.
Discussion
Aurigemma et al.[5]) showed that in patients with hypertensive left ventricular
hypertrophy with preserved left ventricular ejection fraction, midwall fractional shortening
(FS) decreased, and endocardial FS increased compared with those in the controls. Moreover,
the difference between increased endocardial FS and decreased midwall FS in individual cases
correlated with wall thickness, suggesting that midwall FS indicates “myocardial function,
endocardial FS indicates “chamber function, and left ventricular hypertrophy compensated for
reduced “myocardial function” and maintained heart “chamber function”. Okada et
al.[6]), who studied CS
and LS for each layer in patients with hypertrophic cardiomyopathy, demonstrated reduced
CSmid and maintained CSinner in those patients, indicating that lower CSmid reflected
impaired myocardial function and maintained CSinner associated with the maintenance of
chamber function. We were interested in these reports and performed layer-specific CS and LS
in this case. As a result, CSouter, CSmid, and CSinner severely decreased in the apex at
early onset. However, subsequently, the apex showed a sharp tendency of improvement in
CSinner when an APH-like morphology was exhibited. The lack of improvement in CSouter and
CSmid might indicate that the myocardial function had not recovered. In the apex, even when
the APH-like morphology disappeared, LS was not normalized in all layers, indicating that
myocardial function was not restored, although heart chamber function was maintained. We
believe that the apex morphology of our patient contributed to the maintenance of chamber
function and cardiac output.
Conclusion
We believe that LS and CS mid, which indicate myocardial function, contribute to the
evaluation of myocardial function in Takotsubo cardiomyopathy patients with APH-like
morphological changes during the recovery process. Moreover, the CSinner, which indicates
the chamber function, shows an improvement in apparent wall motion.